| Hang Seng Index | 25.480 HKD | +0.160 | +0.632% | 358.04M | 9.11B | 23.260 (+9.545%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 92.500 HKD | +0.500 | +0.543% | 79.41M | 7.34B | 86.975 (+6.352%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.480 HKD | +0.040 | +0.735% | 991.07M | 5.43B | 5.580 (-1.796%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.640 HKD | +0.085 | +1.530% | 171.93M | 967.19M | 6.590 (-14.416%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.548 HKD | -0.022 | -1.401% | 311.93M | 482.85M | 1.831 (-15.475%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.040 HKD | -0.026 | -1.258% | 117.13M | 239.32M | 2.726 (-25.162%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.710 HKD | +0.080 | +1.421% | 28.07M | 159.71M | 5.000 (+14.207%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 11.750 HKD | +0.090 | +0.772% | 10.68M | 125.45M | 12.133 (-3.154%) HKD as at 2025/02/24 | | |
| Hang Seng TECH Index | 5.565 HKD | +0.040 | +0.724% | 21.47M | 119.38M | 5.659 (-1.652%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 10.780 HKD | +0.040 | +0.372% | 10.26M | 110.49M | 10.808 (-0.262%) HKD as at 2025/02/24 | | |
| CSI 300 | 46.660 HKD | +0.300 | +0.647% | 1.62M | 75.22M | 43.473 (+7.330%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 14.800 HKD | +0.030 | +0.203% | 2.63M | 38.87M | 13.749 (+7.644%) HKD as at 2025/02/24 | | |
| HSI ESG Enhanced Index (net total return index) | 52.460 HKD | +0.180 | +0.344% | 730.35K | 38.33M | 47.751 (+9.861%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,433.000 HKD | +13.000 | +0.537% | 11.81K | 28.69M | N/A | | |
| CME Ether Futures | 18.140 HKD | +0.870 | +5.038% | 1.44M | 25.84M | 13.011 (+39.422%) HKD as at 2025/02/24 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 9.135 HKD | +0.445 | +5.121% | 2.84M | 25.76M | 5.740 (+59.155%) HKD as at 2025/02/25 | | |
| Hang Seng High Dividend Yield | 29.520 HKD | +0.400 | +1.374% | 781.36K | 22.95M | 24.714 (+19.446%) HKD as at 2025/02/24 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.800 HKD | +0.020 | +0.135% | 1.11M | 16.20M | 11.063 (+33.782%) HKD as at 2025/02/25 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 15.680 HKD | -0.240 | -1.508% | 847.40K | 13.33M | 10.297 (+52.274%) HKD as at 2025/02/25 | | |
| FTSE US Treasury 20+ Years Index | 67.100 HKD | +0.220 | +0.329% | 193.74K | 12.95M | 70.043 (-4.202%) HKD as at 2025/02/24 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.295 HKD | +0.090 | +0.978% | 1.10M | 10.24M | 10.021 (-7.242%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 13.790 HKD | +0.040 | +0.291% | 727.94K | 10.03M | 12.681 (+8.743%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.886 HKD | -0.004 | -0.103% | 2.32M | 9.02M | 4.925 (-21.101%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.250 HKD | +0.170 | +0.995% | 515.20K | 8.88M | 13.980 (+23.394%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.550 HKD | +0.040 | +1.140% | 2.32M | 8.22M | 3.260 (+8.912%) HKD as at 2025/02/25 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.900 HKD | +0.225 | +2.326% | 744.82K | 7.33M | 8.951 (+10.600%) HKD as at 2025/02/25 | | |
| CSI Hong Kong Dividend | 37.500 HKD | +0.280 | +0.752% | 193.80K | 7.25M | 32.341 (+15.951%) HKD as at 2025/02/25 | | |
| NASDAQ-100 Index | 442.600 HKD | +0.600 | +0.136% | 15.36K | 6.80M | 404.273 (+9.481%) HKD as at 2025/02/24 | | |
| CSI RAFI 50 | 7.950 HKD | -0.030 | -0.376% | 805.90K | 6.36M | N/A | | |
| Hang Seng Index | 10.800 HKD | +0.020 | +0.186% | 568.50K | 6.14M | 10.736 (+0.598%) HKD as at 2025/02/24 | | |